Health insurance companies selling private Medicare Advantage (MA) plans will pay a higher rate in 2026 if the incoming Trump administration adopts the Biden administration’s latest proposal.
The hike would equate to an additional $21 billion in payments to MA plans over the year. It would bolster revenue for companies such as UnitedHealthcare and Humana, which together account for almost half of all MA enrollment in 2024, serving 15.4 million people.
CMS projects $9.2 trillion in payments to MA plans over the next decade, with $1.3 trillion allocated for supplemental benefits and premium buy-downs. The agency said it opted not to pause growth rates related to medical education costs or the three-year phase-in of the updated risk adjustment model, changes that would have added $10.4 billion to MA payments in 2026.
Those changes were unnecessary, according to CMS, since MA offerings for people with Medicare remained stable, with premiums, supplemental benefits, and coverage options largely unchanged since last year.
Insurance companies have complained that recent payment rates have failed to keep pace with rising medical costs, driving down their stock prices. Shares of major MA players, including UnitedHealthcare, Humana, CVS, and Centene, fell last April after the Biden administration moved forward with the 0.16 percent base rate cut.
CMS is accepting public comments on the proposal until Feb. 10.
The MA program, also known as Medicare Part C, is an alternative to traditional Medicare. MA plans are sold by private insurers under contracts with the federal government, often bundling Medicare Part D prescription drug coverage and additional benefits such as dental, vision, and hearing care.
The average monthly plan premium for all MA plans is expected to decrease from $18.23 in 2024 to $17 in 2025.







